A start-up that provides a technology that filters movies for profanity, violence and other objectionable content has vowed to take a copyright battle against Hollywood all the way to the U.S. Supreme Court after a federal judge granted an injunction blocking its service.
One major medical malpractice suit can financially ruin an unprepared physician, hospital or medical practice. Since doctors, hospitals and other health care professionals risk lawsuits, they obviously need insurance to cover this contingency. Medical professionals, known for a thorough, methodical and scientific orientation, should have exacting protocols when shopping for medical malpractice insurance.
Part One of a Two-Part Article
There are many family law issues, both mundane and unique, facing a client who is either a professional athlete or married to one. If such a case is offered to you, will you accept it? And if you do, what issues should you expect to encounter?
Part One of a Two-Part Article
In civil litigation, when retained or testifying experts err materially, causing a case or settlement loss, do they get some kind of immunity so that access to experts is not "chilled" by allowing experts to be sued frequently? The answer to this question is not so easy.
Relationship building between in-house and outside attorneys is key to managing a product liability lawsuit. Trust is the core of the relationship.
This two-part article aims to deconstruct the new joint infringement standard, provide insight into how the standard might be interpreted and provide practice tips for prosecution and litigation. Part 1 chronicles the Akamai cases that ultimately resulted in a new standard for joint infringement and explores the potential interpretations of that standard.
The Mysteries and The Risks
The triple net lease, or NNN (also known as a bondable lease), is a common lease structure used in commercial real estate. Even though it has become widely popular, the most seasoned investors and their advisers do not always fully understand the details.
Abbott Laboratories' $5.8 billion proposed purchase of Alere, a Massachusetts medical testing company, is in trouble now that multiple criminal allegations have been leveled against Alere.
